Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology
Edmonton, Alberta, Canada
Research institute in Edmonton, Alberta
8708 155 St NW Unit 410, Edmonton, AB T5R 1W2
About Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Eli Lilly and Company
3
Gilead Sciences
2
Biogen
1
Intercept Pharmaceuticals
1
Millennium Pharmaceuticals, Inc.
1
Shire
1
Clinical Trials at Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology
During the past decade, Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
2004-03-01
2005-03-01
Completed
462
Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis
2005-04-08
2009-09-07
Completed
829
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
2008-12-01
2012-05-01
Completed
1,116
A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
2010-10-01
2013-09-01
Completed
324
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
2014-05-21
2020-04-16
Completed
609
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors
2014-12-24
2020-06-23
Completed
397
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Eli Lilly and Company" with 3 trials
sponsored, "Gilead Sciences" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Intercept Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology"
#1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology
According to Clinical.Site data, the most researched conditions in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" are
"Crohn's Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Crohn Disease" (2 trials), "Chronic Hepatitis C Infection" (1 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" in a lesser frequency.
Clinical Trials Intervention Types at Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology
Most popular intervention types in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" are "Drug" (14 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Etrolizumab" (4 trials), "Mirikizumab" (2 trials), "Asacol" (1 trials) and "Copegus®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology
The vast majority of trials in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology" are
14 trials for "All" genders.
Clinical Trials Status at Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology
Currently, there are NaN active trials in "Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Zeidler Ledcor Centre - University of Alberta; Division of Gasroenterology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".